CD47 and myelodysplastic syndrome: One study showed that CD47 expression in MDS gradually increased with the evolution of risk scores in the International Prognostic Scoring System (IPSS-R), suggesting that CD47 expression levels may contribute to the progression from MDS to AML (27).